SafeBeat Rx
PrivateLast Round
Grant
Sep 17, 2024
Est. Valuation
$1.79M
Total Funding Raised
$1.73M
Company Overview
SafeBeat Rx is a medical technology company that develops artificial intelligence-based software for remote cardiac patient monitoring. The company's platform integrates with third-party FDA-cleared wearables to allow physicians to monitor patients and guide cardiac therapeutics from a mobile phone, aiming to replace the need for hospitalization for medication initiation and monitoring. Founded in 2020 and a participant in the Y Combinator (S21) accelerator program, SafeBeat Rx was co-founded by Dr. Rachita Navara, a cardiologist and bioengineer, and Dr. Kunj Patel, a physician with expertise in applied mathematics. The software is designed to automate ECG measurements, recommend drug dosing, and detect heart rhythm changes.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Telemedicine, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SafeBeat Rx Comps
Public and private peers based on sector, stage, and business model.
SafeBeat Rx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 17, 2024 | ||||
| Grant | Jul 19, 2024 | ||||
| Accelerator | Oct 9, 2022 | ||||
| Angel | Jul 3, 2022 | ||||
| Accelerator | Jun 7, 2022 | ||||
Seed | Aug 31, 2021 |
SafeBeat Rx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zillionize | Seed |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Y Combinator | Seed |
| HealthTech Arkansas | Accelerator |
| National Heart, Lung, and Blood Institute | Grant |
SafeBeat Rx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SafeBeat Rx's valuation, stock price, and market status.
